Darius Desai
Surgical Oncology · Easton, PANPI 1669486882
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (50.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 71.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $2,150 and has fallen 79.7% since, to $436 in 2025.
Across 45 payments — averaging $145.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Angiodynamics, Inc.$766
- Johnson & Johnson$205
- Merck$186
- Dilon Technologies, Inc.$172
- Integra Lifesciences Corporation$158
- plus $376 from 4 others
Across 27 payments — averaging $1890.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Angiodynamics, Inc.$51K
What the payments were for
- Travel & lodging$3,27450%
- Food & beverage$2,20434%
- Education$1,06816%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 29 | $4,683 |
| Angiodynamics, Inc. | 6 | $766 |
| Johnson & Johnson | 2 | $205 |
| Merck | 2 | $186 |
| Dilon Technologies, Inc. | 1 | $172 |
| Integra Lifesciences Corporation | 1 | $158 |
| Boston Scientific | 1 | $125 |
| Novocure Inc. | 1 | $116 |
| AstraZeneca | 1 | $68 |
| Olympus America Inc. | 1 | $67 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,311
- DAVINCI XI$1,000
- Nanoknife$631
- HemoBlast Bellows$172
- CODMAN CERTAS$158
- CUSA CLARITY$158
- CODMAN HAKIM$158
- DURASEAL EXACT SPINAL SEALANT SYSTEM$158
- AXIOS$125
- Echelon Circular$120
- OPTUNE LUA (NOVOTTF-200T)$116
How this compares
$6,546 in reported general payments places this provider in the 80th percentile of 78 surgical oncology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 19 | $13,724 |
| Oxycodone Hcl | 46 | $136 |
Paid to pharmacies, not to this prescriber.
Other surgical oncology in Easton
- Roderick QuirosEaston$8K
- Jacquelyn CarrEaston$3K
- Richard BleicherPhiladelphia$53K
- Catherine CarruthersSouthampton$17K
- Nestor EsnaolaPhiladelphia$17K
- Andrea PorpigliaPhiladelphia$11K
- William MoranoWynnewood$11K
- Matthew HoltzmanPittsburgh$11K
- Arvind SabesanWynnewood$10K
- Stacy KrisherBensalem$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.